QCH Report FINAL V2 - Flipbook - Page 46
Queenscourt Hospice (Registered company number 2102320)
Notes to the Financial Statements
For the year ended 31 March 2024
22
Related party transactions
On consolidation all transactions and closing balances with wholly owned subsidiary entities
are netted against each other. The Trustees review Related Parties on a regular basis and
deem no further transactions in the period to require disclosure.
23
Donated goods
Queenscourt Hospice Retail Ltd acts as an agent in selling donated goods and charged
commission of £1,057 (2023: £1,258) for these services.
24
Drugs
NHS Cheshire & Merseyside Integrated Care Board contributed £39,126 (2023: £34,530)
towards drugs supplied by Southport and Ormskirk NHS Trusts.
25
Prior period adjustments
There are two small adjustments to the consolidated (group) accounts which are deemed as
immaterial. The Consolidated Statement of Financial Activities (for both the Group and Charity)
has an additional expenditure line for the costs of investment property management. This figure
of £24,603 has been deducted from expenditure on charitable activities. This also affects note
7 to the accounts.
In note 7 to the accounts, travel expenses (£36,827) have been taken out of staff costs and are
now included in the transport and travel heading. Accordingly, the staff costs in note 10 (for
both the Group and the Charity) have been reduced by this amount.
Note 7 has now been expanded to fully reflect the costs of Governance of the Charity.
Note 3 to the accounts has been adjusted by £160,152 so as to include End of Life Monies
received from Cheshire and Merseyside ICB in the NHS Cheshire & Merseyside and Lancashire
& South Cumbria ICBs line, having been removed from the line for Medical Income and Course
Fees.
All adjustments made in respect of the prior year are restatement and presentational only, there
has been no effect on the surplus/(deficit) previously reported by the Parent Charity (the Group)
or its subsidiaries.
P a g e | 46
